Title |
Emergent BioSolutions - Protection through prevention - BioThrax |
Description |
Emergent BioSolutions Inc. is a global biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the body’s immune system to prevent or treat disease. Emergent’s marketed and investigational products target infectious diseases, oncology, and autoimmune disorders. BioThrax is the only FDA-licensed vaccine available for pre-exposure protection against anthrax infection. According to the Centers for Disease Control and |
Keywords |
active immunization of adults, anthrax infection, anthrax vaccine, anthrax vaccine adsorbed, anthrax vaccine efficacy, biothrax, biothrax anthrax vaccine, biothrax efficacy, biothrax vaccine, cdc, centers for disease control and prevention, emergent biosolutions, exposure to anthrax, exposure to anthrax, fda-licensed, high risk, nthrax vaccine efficacy, only us anthrax vaccine, pre-exposure protection, protection through prevention, recommendations for biothrax use, recommended to prevent anthrax, recommended uses, threats to the public, vaccine, vaccine against anthrax, weaponized anthrax
|
|